Cargando…

Emodin exerts antitumor effects in ovarian cancer cell lines by preventing the development of cancer stem cells via epithelial mesenchymal transition

Ovarian cancer has the worst prognosis among all types of gynecological malignancies and patients are often diagnosed at an advanced stage with distant metastasis. In the present study, it was found that emodin, a small molecular chemical drug derived from natural plants, has antitumor effects on ov...

Descripción completa

Detalles Bibliográficos
Autores principales:	Long, Heming, Chen, Hongmei, Yan, Jun, Cheng, Haiyan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2022
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8822392/ https://www.ncbi.nlm.nih.gov/pubmed/35154426 http://dx.doi.org/10.3892/ol.2022.13215

Ejemplares similares

Emodin Inhibits the Epithelial to Mesenchymal Transition of Epithelial Ovarian Cancer Cells via ILK/GSK-3β/Slug Signaling Pathway
por: Lu, Jingjing, et al.
Publicado: (2016)

Juglone exerts antitumor effect in ovarian cancer cells
por: Fang, Fang, et al.
Publicado: (2015)

Resveratrol Inhibits Cisplatin-Induced Epithelial-to-Mesenchymal Transition in Ovarian Cancer Cell Lines
por: Baribeau, Sébastien, et al.
Publicado: (2014)

Emodin reverses resistance to gemcitabine in pancreatic cancer by suppressing stemness through regulation of the epithelial‑mesenchymal transition
por: Wei, Weitian, et al.
Publicado: (2022)

MicroRNA-126 exerts antitumor functions in ovarian cancer by targeting EGFL7 and affecting epithelial-to-mesenchymal transition and ERK/MAPK signaling pathway
por: Zhang, Yuhua, et al.
Publicado: (2020)

Emodin reduces Breast Cancer Lung Metastasis by suppressing Macrophage-induced Breast Cancer Cell Epithelial-mesenchymal transition and Cancer Stem Cell formation
por: Liu, Qing, et al.
Publicado: (2020)

Emodin Inhibits Colon Cancer Cell Invasion and Migration by Suppressing Epithelial–Mesenchymal Transition via the Wnt/β-Catenin Pathway
por: Gu, Juan, et al.
Publicado: (2019)

Emodin inhibiting neutrophil elastase‐induced epithelial‐mesenchymal transition through Notch1 signalling in alveolar epithelial cells
por: Zhou, Linshui, et al.
Publicado: (2020)

Targeting epithelial-mesenchymal transition and cancer stem cells for chemoresistant ovarian cancer
por: Deng, Junli, et al.
Publicado: (2016)

Thrombin promotes epithelial ovarian cancer cell invasion by inducing epithelial-mesenchymal transition
por: Zhong, Yi-Cun, et al.
Publicado: (2013)

Emodin Reverses the Epithelial–Mesenchymal Transition of Human Endometrial Stromal Cells by Inhibiting ILK/GSK-3β Pathway
por: Zheng, Qiaomei, et al.
Publicado: (2020)

Epithelial–Mesenchymal Transition: Role in Cancer Progression and the Perspectives of Antitumor Treatment
por: Gaponova, A. V., et al.
Publicado: (2020)

Salinomycin-Loaded High-Density Lipoprotein Exerts Promising Anti-Ovarian Cancer Effects by Inhibiting Epithelial–Mesenchymal Transition
por: Zou, Miao, et al.
Publicado: (2022)

Emodin ameliorates bleomycin-induced pulmonary fibrosis in rats by suppressing epithelial-mesenchymal transition and fibroblast activation
por: Guan, Ruijuan, et al.
Publicado: (2016)

Knockout of MTF1 Inhibits the Epithelial to Mesenchymal Transition in Ovarian Cancer Cells
por: Ji, Liang, et al.
Publicado: (2018)

EZH2 inhibition promotes epithelial-to-mesenchymal transition in ovarian cancer cells
por: Cardenas, Horacio, et al.
Publicado: (2016)

The FGFR Family Inhibitor AZD4547 Exerts an Antitumor Effect in Ovarian Cancer Cells
por: Na, Yu Ran, et al.
Publicado: (2021)

Antitumor Effects and Mechanism of Novel Emodin Rhamnoside Derivatives against Human Cancer Cells In Vitro
por: Xing, Jie-yu, et al.
Publicado: (2015)

Mitochondrial dysfunction and epithelial to mesenchymal transition in head neck cancer cell lines
por: Greier, Maria Carmo, et al.
Publicado: (2022)

Cyclin D1 affects epithelial–mesenchymal transition in epithelial ovarian cancer stem cell-like cells
por: Jiao, Jie, et al.
Publicado: (2013)

NANOG regulates epithelial–mesenchymal transition and chemoresistance in ovarian cancer
por: Qin, Shan, et al.
Publicado: (2017)

DPY30 is required for the enhanced proliferation, motility and epithelial-mesenchymal transition of epithelial ovarian cancer cells
por: Zhang, Lili, et al.
Publicado: (2018)

Pristimerin exerts antitumor activity against MDA-MB-231 triple-negative breast cancer cells by reversing of epithelial-mesenchymal transition via downregulation of integrin β3
por: Liu, Shiyue, et al.
Publicado: (2021)

Emodin enhances antitumor effect of paclitaxel on human non-small-cell lung cancer cells in vitro and in vivo
por: Chen, Shuifang, et al.
Publicado: (2019)

Neutrophil Granulocytes in Ovarian Cancer - Induction of Epithelial-To-Mesenchymal-Transition and Tumor Cell Migration
por: Mayer, Christine, et al.
Publicado: (2016)

Overexpression of TAZ promotes cell proliferation, migration and epithelial-mesenchymal transition in ovarian cancer
por: Chen, Guangyuan, et al.
Publicado: (2016)

CD73 Regulates Stemness and Epithelial-Mesenchymal Transition in Ovarian Cancer-Initiating Cells
por: Lupia, Michela, et al.
Publicado: (2018)

ELF3 is a negative regulator of epithelial-mesenchymal transition in ovarian cancer cells
por: Yeung, Tsz-Lun, et al.
Publicado: (2017)

Relationship between ovarian cancer stem cells, epithelial mesenchymal transition and tumour recurrence
por: Padilla, Monica Angelica Amaya, et al.
Publicado: (2019)

Selective emodin toxicity in cancer cells
por: Kolitsida, Panagiota, et al.
Publicado: (2017)

Investigation of role of CpG methylation in some epithelial mesenchymal transition gene in a chemoresistant ovarian cancer cell line
por: Alghamian, Yaman, et al.
Publicado: (2022)

Epithelial-to-mesenchymal transition markers are differentially expressed in epithelial cancer cell lines after everolimus treatment
por: Gonçalves, Bryan Ôrtero Perez, et al.
Publicado: (2020)

Epithelial–Mesenchymal Transition in Ovarian Carcinoma
por: Davidson, Ben, et al.
Publicado: (2012)

miR-506 Regulates Epithelial Mesenchymal Transition in Breast Cancer Cell Lines
por: Arora, Himanshu, et al.
Publicado: (2013)

Protein expression patterns in cancer-associated fibroblasts and cells undergoing the epithelial-mesenchymal transition in ovarian cancers
por: Fukagawa, Daisuke, et al.
Publicado: (2018)

Low-dose eribulin mesylate exerts antitumor effects in gastric cancer by inhibiting fibrosis via the suppression of epithelial–mesenchymal transition and acts synergistically with 5-fluorouracil
por: Kurata, Toru, et al.
Publicado: (2018)

Sensitization of Non-Small Cell Lung Cancer Cells to Gefitinib and Reversal of Epithelial–Mesenchymal Transition by Aloe-Emodin Via PI3K/Akt/TWIS1 Signal Blockage
por: Peng, Minghui, et al.
Publicado: (2022)

Coumarin Derivatives Exert Anti-Lung Cancer Activity by Inhibition of Epithelial–Mesenchymal Transition and Migration in A549 Cells
por: de Araújo, Rodrigo Santos Aquino, et al.
Publicado: (2022)

HPIP Silencing Prevents Epithelial–Mesenchymal Transition Induced by TGF-β1 in Human Ovarian Cancer Cells
por: Zhang, Guo-ying, et al.
Publicado: (2016)

Epigenomic Reprogramming toward Mesenchymal-Epithelial Transition in Ovarian-Cancer-Associated Mesenchymal Stem Cells Drives Metastasis
por: Fan, Huihui, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_fpsieffja613uf0ghj78nqpohh